1 active not recruiting, 1 completed. .
Follow Notable Labs: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration Peripheral blood draw, Bone marrow aspirate, Buccal swab - Acute Myeloid Leukemia, Myelodysplastic Syndromes | Active not recruiting | Washington University School of Medicine | 80 | 2020-01-29 | 2026-03-02 | |
| Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy This is a non-interventional study - Acute Myelogenous Leukemia, Multiple Myeloma | Completed | Notable Labs | 119 | 2019-12-15 | 2022-04-05 |
Leukemia, Myeloid, Acute (2) · Myelodysplastic Syndromes (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Lymphoma (1) · Multiple Myeloma (1) · Myeloproliferative Disorders (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
United States (2) · Greece (1) · Spain (1)
Hiroomi Tada, MD, Ph.D. (1) · Meagan Jacoby, M.D. (1)